Scholarly Index
Donna M. Wilcock
Institute for Neurodegenerative Disorders; 14,522 total citations; 271 total publications; best world rank #100
Institute for Neurodegenerative Disorders
14,522Total citations
271Total publications
59H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Neuroinflammation and Neurodegeneration Mechanisms | Lifetime | 324 | US 146 | 98.82 |
| Alzheimer's disease research and treatments | Lifetime | 510 | US 254 | 98.73 |
| Neurological Disease Mechanisms and Treatments | Lifetime | 362 | US 142 | 97.10 |
| S100 Proteins and Annexins | Lifetime | 813 | US 353 | 93.54 |
| Cerebrovascular and genetic disorders | Lifetime | 357 | US 94 | 87.96 |
| Down syndrome and intellectual disability research | Lifetime | 441 | US 169 | 86.45 |
| GDF15 and Related Biomarkers | Lifetime | 608 | US 195 | 79.93 |
| Neuroinflammation and Neurodegeneration Mechanisms | 2021-2025 | 133 | US 44 | 97.01 |
| Neurological Disease Mechanisms and Treatments | 2021-2025 | 100 | US 25 | 92.91 |
| Alzheimer's disease research and treatments | 2021-2025 | 432 | US 177 | 95.33 |
| Dementia and Cognitive Impairment Research | 2021-2025 | 662 | US 273 | 94.68 |
| S100 Proteins and Annexins | 2021-2025 | 293 | US 57 | 77.66 |
| Cerebrovascular and genetic disorders | 2021-2025 | 370 | US 55 | 55.85 |
| Down syndrome and intellectual disability research | 2021-2025 | 902 | US 330 | 44.40 |
| GDF15 and Related Biomarkers | 2021-2025 | 954 | US 232 | 41.12 |